Atrial Fibrillation Research Database

• Conditions: Anticoagulants and Bleeding Disorders; Atrial Fibrillation

• Registration Number: NCT03760874
• Lead Sponsor: University of Campania "Luigi Vanvitelli"

Brief Summary

All patients with atrial fibrillation who are treated with vitamin-k antagonists (warfarin, phenprocoumon) or non vitamin K oral anticoagulants (Dabigatran, Rivaroxaban, Apixaban, Edoxaban) in real world settings will be recorded in this register. Within this register a characterization of patients and therapy (with regard to medication, dose and duration) will be done. On basis of defined clinical relevant end points the long-term efficacy and safety will be evaluated.

Detailed Description

Not available

Study Timeline

• Study Start: 2013-06-13
• Study First Submitted: 2018-11-27
• Study First Submitted QC: 2018-11-29
• Study First Posted: 2018-11-30
• Status Verified: 2020-06
• Last Update Submitted: 2020-06-10
• Last Update Posted: 2020-06-11
• Primary Completion: 2022-01-01
• Study Completion: 2023-01-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 5000

Inclusion Criteria

• Patients with atrial fibrillation
• Indication for oral anticoagulant treatment

Exclusion Criteria

• Missing Informed Consent Form
• Missing Contact Informations for Follow up

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Bleeding Events	1 year
Thromboembolic Events	1 year

Trial Locations

Locations (1)

University of Campania "Luigi Vanvitelli"; 🇮🇹 Naples, Italy